Journal Logo

Articles by M. Abbenante

PS997 A NEW BIOMARKER OF RESPONSE TO 5-AZACITIDINE THERAPY IN MDS AND AML PATIENTS: SIRPB1

Cerchione, C.; Guadagnuolo, V.; Papayannidis, C.; More

HemaSphere. 3(S1):448-449, June 2019.

PB1726 DOUBLE FLUDARABINE-BASED INDUCTION AND INFECTIVE RISK: THE BOLOGNA EXPERIENCE.

Sartor, C.; De Polo, S.; Lewis, R.E.; More

HemaSphere. 3(S1):794, June 2019.